Ticker LaunchCanada to US · Cross-listing · EPRX
Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Inc. (EPRX), a British Columbia-based company, cross-listed on Nasdaq on Jan 18, 2024, registering its securities on Form 8-A12B.
Eupraxia Pharmaceuticals Inc. is a clinical-stage biotechnology company using its proprietary Diffusphere technology to optimize drug delivery. Its product candidates are designed to give longer-lasting activity and targeted local delivery for conditions with significant unmet medical need.
- Type
- Cross-listing
- US exchange
- Nasdaq
- Ticker
- EPRX
- Listed
- Jan 18, 2024
- Province
- British Columbia
- Registration form
- 8-A12B
- Security
- Common shares
- Sector
- Biotech & pharma
More on this listing for subscribers
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration (8-A12B) Jan 18, 2024
- Offering document
- All filings on EDGAR CIK 1581178
Other Canadian companies listing in the US
- Damon Inc.Nasdaq · Jul 25, 2024
- Collective Mining Ltd.NYSE American · Jul 10, 2024
- South Bow CorporationNYSE · Apr 16, 2024
- POWERBANK CorporationNasdaq · Mar 11, 2024
- Aris Mining CorporationNYSE American · Sep 6, 2023
- Lithium Americas Corp.NYSE · Aug 22, 2023